Xiao Fang, Xiao Songshu, Xue Min
Department of Obstetrics and Gynecology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, People's Republic of China.
Onco Targets Ther. 2019 Dec 6;12:10727-10737. doi: 10.2147/OTT.S221236. eCollection 2019.
Emerging proof suggests that microRNA (miRNA) malfunction is correlated to the generation and development of multiple malignancies. It has been proven that miRNA (miR)-139 represses a variety of malignancies. However, the understanding of its impact on ovarian cancer (OC) is insufficient. We aimed to investigate the expression and function of miR-139 in OC.
The expression of mir-139 was detected and recorded, and the relationship of mir-139 remaining OC cells was explored. At the same time, we studied the correlation between ATP7A and mir-139 by the luciferase reporter test, Western blot, and quantitative real-time reverse transcription PCR.
The expression of miR-139 was remarkably downregulated in OC specimens. Furthermore, excessive miR-139 expression noticeably inhibited the migration, colony generation, proliferation, and invasion of OC cells. In addition, excessive miR-139 expression remarkably repressed the death and the expression of proteins related to cell death in OC cells, as well as inhibited the shedding of exosomes. According to the luciferase reporter test, Western blot, and quantitative real-time reverse transcription PCR, miR-139 directly targeted ATP7A. Furthermore, the expression of ATP7A was found to be negatively related to miR-139 levels in OC specimens. It was revealed via a rescue experiment that excessive ATP7A expression counteracted the repressive effect of miR-139 in OC cells.
It was revealed via an in vivo study that miR-139 remarkably inhibited the growth of malignancies by downregulating ATP7A in nude mice. miR-139 represses the development of malignancies in OC by directly targeting ATP7A, offering an innovative approach for molecular therapy of OC.
新出现的证据表明,微小RNA(miRNA)功能异常与多种恶性肿瘤的发生和发展相关。已经证明,miRNA(miR)-139可抑制多种恶性肿瘤。然而,对其在卵巢癌(OC)中的作用了解不足。我们旨在研究miR-139在OC中的表达及功能。
检测并记录mir-139的表达情况,探讨mir-139与OC细胞的关系。同时,通过荧光素酶报告基因检测、蛋白质印迹法和定量实时逆转录PCR研究ATP7A与mir-139之间的相关性。
miR-139在OC标本中的表达明显下调。此外,miR-139表达过量显著抑制了OC细胞的迁移、集落形成、增殖和侵袭。此外,miR-139表达过量还显著抑制了OC细胞的死亡及与细胞死亡相关的蛋白质表达,同时抑制了外泌体的释放。根据荧光素酶报告基因检测、蛋白质印迹法和定量实时逆转录PCR结果,miR-139直接靶向ATP7A。此外,在OC标本中发现ATP7A的表达与miR-139水平呈负相关。通过挽救实验发现,ATP7A表达过量可抵消miR-139对OC细胞的抑制作用。
体内研究表明,miR-139通过下调裸鼠体内的ATP7A显著抑制恶性肿瘤生长。miR-139通过直接靶向ATP7A抑制OC中恶性肿瘤的发展,为OC的分子治疗提供了一种创新方法。